The report provides a detailed analysis essential for establishing a Metaproterenol production plant. It encompasses all critical aspects necessary for Metaproterenol production, including the cost of Metaproterenol production, Metaproterenol plant cost, Metaproterenol production costs, and the overall Metaproterenol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Metaproterenol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Metaproterenol is a medicine that is used to help people breathe easier when they have asthma or lung problems like bronchitis and emphysema. It works by relaxing and opening up the air passages in the lungs, which helps stop wheezing, coughing, and chest tightness. It is used for the treatment of acute asthma attacks and bronchospasm associated with chronic obstructive pulmonary disease by relaxing airway smooth muscles and facilitating easier breathing. It is also utilised in veterinary medication for treating bradycardia (slow heart rate). It mimics adrenaline but with less intense cardiovascular stimulation. Its side effects include mild tachycardia, tremors, and nervousness, with more rare reactions like dizziness and chest pain.
The market for metaproterenol is driven by the increasing global prevalence of respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. The rise in healthcare expenditure and greater awareness about respiratory health contribute to its market growth. The shift towards more convenient drug delivery methods like inhalers and nebulisers enhances patient compliance and treatment efficacy, making it a popular product.
The industrial metaproterenol procurement is influenced by its clinical use and availability in affordable generic versions. The North American and European regions lead their markets because of higher healthcare spending, while the Asia-Pacific region is growing due to increased healthcare access and rising respiratory disease prevalence. Also, innovation in formulations and delivery systems, along with rising healthcare infrastructure investments and government support, impacts its sourcing strategies.
Raw Material for Metaproterenol Production
According to the Metaproterenol production plant project report, the key raw materials used in the production of Metaproterenol include (3,5-Diacetoxyacetophenone)-Bromine- Isopropylamine-Methanol.
Production Process of Metaproterenol
The extensive Metaproterenol production cost report consists of the following major industrial production process:
- From 3,5-Diacetoxyacetophenone, Bromine, and Isopropylamine: The production process of Metaproterenol starts with a reaction between 3,5-diacetoxyacetophenone and bromine. This reaction is followed by treatment with isopropylamine to form 1-(3,5-dihydroxyphenyl)-2-isopropylaminoethanone. The obtained product was dissolved in methanol and subjected to catalytic hydrogenation using Raney nickel at room temperature under moderate pressure. Finally, the catalyst was removed by filtration, and the resulting filtrate, Metaproterenol, was mixed with an alcoholic sulfuric acid solution to precipitate its sulfate salt.
Metaproterenol is a white crystalline powder with the molecular formula C11H17NO3 and a molecular weight of 211.26 g/mol. It is a beta2-adrenergic agonist that is used primarily as a bronchodilator. It has a melting point around 104–105 degree Celsius. It is soluble in water and alcohol, with moderate lipophilicity indicated by a logP value of about 0.7. It contains four hydrogen bond donors and several acceptors, contributing to its interactions in biological systems. Its physical and chemical properties, such as solubility, melting point, and stability, are important for formulation and pharmaceutical applications.